Evaluation of Glycemic Impact on Fetal Liver Length and Volume by Ultrasound in Pregnancy
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-52
SponsorAssiut University
About this trial
The primary aim of this study is to evaluate whether fetal liver length and volume, as assessed by ultrasound, can serve as reliable markers of the metabolic impact of Gestational Diabetes Mellitus (GDM) on the fetus.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
gestational age 24wks-36wks by an early pregnancy ultrasound exam including CRL length
normal maternal blood sugar levels in early pregnancy
diagnosed as GDM
singleton viable pregnancy
Disqualifiers
preexisting diabetes
fetal congenital anomalies or chromosomal abnormalities
maternal chronic illnesses (e.g. Hypertension , thyroid disorders)
multiple pregnancies
Trial population
Deep learning machine This prospective cohort consisted of pregnant women recruited from the antenatal clinics and fetal-medicine unit at Women's Health Hospital at Assiut University , between \[December 2025 - March 2029\]. Participants were enrolled at the time of their routine mid-trimester/anomaly ultrasound (targeted recruitment window 24weeks gestation for mid-trimester measures, with repeat/late scans at 36 weeks when required for longitudinal liver volume assessment)
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Correlation of fetal liver length with maternal glycemic state
Correlation of fetal liver length with maternal glycemic state
Time frame
12 weeks2
Comparison of fetal liver length
Comparison of fetal liver length between women with gestational diabetes mellitus (GDM) and normoglycemic pregnancies.
Time frame
12 weeks3
Correlation of fetal liver volume with maternal glycemic state
Correlation of fetal liver volume with maternal glycemic state
Time frame
12 weeks4
Comparison of fetal liver volume between women with gestational diabetes mellitus (GDM) and normoglycemic pregnancies.
Comparison of fetal liver volume between women with gestational diabetes mellitus (GDM) and normoglycemic pregnancies.
Time frame
12 weeksSecondary outcomes
1
Correlation of fetal liver size with standard fetal biometry
Correlation of fetal liver size with standard fetal biometry (abdominal circumference, estimated fetal weight).
Time frame
12 weeks2
Relationship of fetal liver measurements with neonatal outcomes
Relationship of fetal liver measurements with neonatal outcomes (birth weight, macrosomia, neonatal hypoglycemia
Time frame
12 weeks3
Comparison of abdominal circumference with fetal liver volume
Comparison of abdominal circumference with fetal liver volume
Time frame
12 weeks4
Comparison of abdominal circumference with fetal liver length
Comparison of abdominal circumference with fetal liver length
Time frame
12 weeksLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: